Intramural Research Training Award Postbaccalaureate
National Institutes of Health
Elizabeth Andrews, B.S. is currently an Intramural Training Research Award Postbaccalaureate Fellow with a joint appointment at the National Human Genome Research Institute and National Cancer Institute, National Institutes of Health, Bethesda, MD. Currently, Ms. Andrews performs clinical research investigating a cohort of patients with germline RUNX1 mutations. Patients with germline RUNX1 disorders often have quantitative and qualitative platelet defects and an increased risk of hematologic malignancies.
Ms. Andrews studied the clinician-administered ISTH-BAT score and the patient self-administered ISTH-BAT score in patients within the NIH RUNX1 Natural History Study Patient population, investigating the concordance of the two scores. Ms. Andrews hopes to further investigate the ISTH-BAT and how it can (1) be modified to improve version interchangeability between the clinician and patient version, and (2) be used to predict platelet quantitative and qualitative abnormalities in this unique patient population.
Ms. Andrews is also helping to determine which validated Patient Reported Outcomes Measures (PROMs) will be the most relevant for patients with germline RUNX1 mutations on upcoming dedicated treatment trials. She also has interest in helping to identify and eliminate barriers to care for patients with germline RUXN1 mutations, especially those from historically underrepresented groups.
Monday, July 11, 2022
6:30 PM – 7:30 PM